drugset / Trial / NCT07312188
A Study of F182112 in the Treatment of Patients With Relapsed or Refractory Multiple Myeloma
NaSequentialOpen-labelTreatment
Summary
This is a single - arm, multi - cohort, open - label, multi - center Phase II clinical study. It aims to evaluate the efficacy and safety of F182112 combined with different administration regimens in patients with relapsed or refractory multiple myeloma.
Timeline
- Start
- 2025-07-02
- Primary completion
- 2028-05-20
- Completion
- 2028-05-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | F182112 | Unknown | — | — |
| Subject | Pomalidomide | Other / unclassified | — | — |